SCHEMBL2889714

SCHEMBL2889714

OC(c1ccccc1)[C@H](O)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.62
ADRA2C P18825 2/20 0.62
KDM4E B2RXH2 2/20 0.62
ADRA2A P08913 1/20 0.62
HIF1A Q16665 1/20 0.62
ALDH1A1 P00352 3/20 0.59
AOC3 Q16853 5/20 0.56
CHRM2 P08172 1/20 0.56
ADRA1A P35348 1/20 0.56
RGS12 O14924 1/20 0.56
GLA P06280 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
PKM P14618 1/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
ALOX12 P18054 1/20 0.56
NFKB1 P19838 1/20 0.56
HTR2A P28223 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL915218 1.00 LMNA (0.62) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL3055513 1.00 LMNA (0.62) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL1711563 1.00 LMNA (0.62) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL29674753 1.00 LMNA (0.62) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL430516 1.00 LMNA (0.62) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL1417856 1.00 LMNA (0.62) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL5598127 0.87 LMNA (0.56) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL14474285 0.87 LMNA (0.56) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL11602702 0.86 IDO1 (0.54) LMNAADRA2CKDM4EADRA2AHIF1A
Phosphoric Acid SCHEMBL4954578 0.86 SRC (0.58) LMNAADRA2CKDM4EADRA2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107428802-B Cyclic peptide compounds, their preparation and use 浙江海正药业股份有限公司 2021-09-28 CN disclosed
EP-3305405-A1 MANGAN(III)-MANGAN(IV) MIXED OXIDE CATALYST CONTAINING AN INTERCALATED CATION X FOR AEROBIC OXIDATIVE CLEAVAGE OF 1,2-DIOLS Centre National De La Recherche Scientifique (FR) 2018-04-11 EP disclosed
CN-107428802-A Cyclic peptide compounds, their preparation and use 浙江海正药业股份有限公司 2017-12-01 CN disclosed
US-9023652-B2 Organometallic sensor device UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD. (GB) 2015-05-05 US disclosed
US-8754234-B2 Chiral 2-(benzylsulfinyl)thiazole derivatives and 2-[(1H-pyrazol-4-ylmethyl)sulfinyl]thiazole derivatives, processes for their preparation and their use as herbicides and plant growth regulators BAYER CROPSCIENCE AG (DE) 2014-06-17 US disclosed
US-8513442-B2 Methods of performing cycloadditions, reaction mixtures, and methods of performing asymmetric catalytic reactions THE UNIVERSITY OF CHICAGO (US) 2013-08-20 US disclosed
US-20100285602-A1 ORGANOMETALLIC SENSOR DEVICE UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD. (GB) 2010-11-11 US disclosed
US-20100285958-A1 Chiral 2-(benzylsulfinyl)Thiazole derivatives and 2-[(1H-pyrazol-4-ylmethyl)sulfinyl]thiazole derivatives, processes for their preparation and their use as herbicides and plant growth regulators BAYER INTELLECTUAL PROPERTY GMBH (DE) 2010-11-11 US disclosed
US-20100184999-A1 Methods of performing cycloadditions, reaction mixtures, and methods of performing asymmetric catalytic reactions THE UNIVERSITY OF CHICAGO 2010-07-22 US disclosed
EP-1181014-B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD BRISTOL MYERS SQUIBB CO (US) 2007-05-23 EP disclosed
US-20030176746-A1 Multifunctional catalyst useful in the synthesis of chiral vicinal diols and process for the preparation thereof, and process for the preparation of chiral vicinal diols using said multifunctional catalysts COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-09-18 US disclosed
US-20030153794-A1 Process for the preparation of supported osmates COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH. 2003-08-14 US disclosed
US-20030105367-A1 Supported osmates, process for preparation thereof, and a process for the preparation of chiral vicinal diols using supported osmate catalyst COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-06-05 US disclosed
WO-2003035253-A1 PROCESS FOR THE PREPARATION OF SUPPORTED OSMATES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-05-01 WO disclosed
US-6552234-B1 Reacting potassium osmate with such as quaternary ammonium divinylbenzene-styrene copolymer COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-04-22 US disclosed
US-6548529-B1 AP2 (adipocyte fatty binding protein); biphenyl-substituted pyrazoles of given formula; treating diabetes and related diseases; mixtures with other antidiabetic agents such as metformin, glyburide, troglitazone and/or insulin BRISTOL-MYERS SQUIBB COMPANY 2003-04-15 US disclosed
EP-1209142-A1 Preparation of new layered double hydroxides exchanged with osmate for asymmetric dihydroxylation of olefins to vicinal diols COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2002-05-29 EP disclosed
US-6387033-B1 CIS ISOMERS FOR HYDROXYLATION OF OLEFINS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2002-05-14 US disclosed
US-6197994-B1 PREPARING VICINAL DIOLS BY CATALYTIC ASYMMETRIC DIHYDROXYLATION OF OLEFINS USING SILICA GEL SUPPORTED BIS-CINCHONA ALKALOID DERIVATIVE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2001-03-06 US disclosed
US-5968867-A REUSABLE CATALYSTS FOR DIHYDROXYLATION OF OLEFINS TO OPTICALLY-ACTIVE VICINAL DIOLS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1999-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100285958-A1 Chiral 2-(benzylsulfinyl)Thiazole derivatives and 2-[(1H-pyrazol-4-ylmethyl)sulfinyl]thiazole derivatives, processes for their preparation and their use as herbicides and plant growth regulators STS, SULT2A1, SLTM LMNA 4704/4885ADRA2C 1902/4885KDM4E 1930/4885
US-20100184999-A1 Methods of performing cycloadditions, reaction mixtures, and methods of performing asymmetric catalytic reactions DCXR, POR, COASY LMNA 4300/4885ADRA2C 1392/4885KDM4E 4614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.